vs

Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $6.1M, roughly 1.2× GSI TECHNOLOGY INC). Lakeside Holding Ltd runs the higher net margin — -22.6% vs -49.7%, a 27.1% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 12.2%).

Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

GSIT vs LSH — Head-to-Head

Bigger by revenue
LSH
LSH
1.2× larger
LSH
$7.0M
$6.1M
GSIT
Growing faster (revenue YoY)
LSH
LSH
+82.8% gap
LSH
95.0%
12.2%
GSIT
Higher net margin
LSH
LSH
27.1% more per $
LSH
-22.6%
-49.7%
GSIT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
GSIT
GSIT
LSH
LSH
Revenue
$6.1M
$7.0M
Net Profit
$-3.0M
$-1.6M
Gross Margin
52.7%
27.2%
Operating Margin
-113.7%
-21.3%
Net Margin
-49.7%
-22.6%
Revenue YoY
12.2%
95.0%
Net Profit YoY
25.0%
18.7%
EPS (diluted)
$-0.09
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GSIT
GSIT
LSH
LSH
Q4 25
$6.1M
$7.0M
Q3 25
$6.4M
$6.1M
Q2 25
$6.3M
$6.3M
Q1 25
$5.9M
$3.8M
Q4 24
$5.4M
$3.6M
Q3 24
$4.5M
$4.1M
Q2 24
$4.7M
Q1 24
$5.2M
Net Profit
GSIT
GSIT
LSH
LSH
Q4 25
$-3.0M
$-1.6M
Q3 25
$-3.2M
$-1.4M
Q2 25
$-2.2M
$-893.1K
Q1 25
$-2.2M
$-1.1M
Q4 24
$-4.0M
$-1.9M
Q3 24
$-5.5M
$-1.3M
Q2 24
$1.1M
Q1 24
$-4.3M
Gross Margin
GSIT
GSIT
LSH
LSH
Q4 25
52.7%
27.2%
Q3 25
54.8%
18.2%
Q2 25
58.1%
26.7%
Q1 25
56.1%
18.8%
Q4 24
54.0%
-1.2%
Q3 24
38.6%
12.8%
Q2 24
46.3%
Q1 24
51.6%
Operating Margin
GSIT
GSIT
LSH
LSH
Q4 25
-113.7%
-21.3%
Q3 25
-49.5%
-20.8%
Q2 25
-34.6%
-8.9%
Q1 25
-38.7%
-28.2%
Q4 24
-74.9%
-55.6%
Q3 24
-122.7%
-32.5%
Q2 24
23.1%
Q1 24
-87.6%
Net Margin
GSIT
GSIT
LSH
LSH
Q4 25
-49.7%
-22.6%
Q3 25
-49.4%
-22.2%
Q2 25
-35.3%
-14.2%
Q1 25
-37.9%
-28.2%
Q4 24
-74.4%
-54.1%
Q3 24
-120.0%
-32.7%
Q2 24
23.1%
Q1 24
-83.9%
EPS (diluted)
GSIT
GSIT
LSH
LSH
Q4 25
$-0.09
$-0.08
Q3 25
$-0.11
$-0.09
Q2 25
$-0.08
$-0.11
Q1 25
$-0.09
$-0.14
Q4 24
$-0.16
$-0.26
Q3 24
$-0.21
$-0.18
Q2 24
$0.04
Q1 24
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GSIT
GSIT
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$70.7M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$83.6M
$12.2M
Total Assets
$98.5M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GSIT
GSIT
LSH
LSH
Q4 25
$70.7M
$1.6M
Q3 25
$25.3M
$4.5M
Q2 25
$22.7M
$5.0M
Q1 25
$13.4M
$1.5M
Q4 24
$15.1M
$1.1M
Q3 24
$18.4M
$2.7M
Q2 24
$21.8M
Q1 24
$14.4M
Total Debt
GSIT
GSIT
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
GSIT
GSIT
LSH
LSH
Q4 25
$83.6M
$12.2M
Q3 25
$38.6M
$7.0M
Q2 25
$37.4M
$2.8M
Q1 25
$28.2M
$749.8K
Q4 24
$29.9M
$1.6M
Q3 24
$33.3M
$3.6M
Q2 24
$38.0M
Q1 24
$36.0M
Total Assets
GSIT
GSIT
LSH
LSH
Q4 25
$98.5M
$24.3M
Q3 25
$52.0M
$18.6M
Q2 25
$50.5M
$14.4M
Q1 25
$43.3M
$9.9M
Q4 24
$44.1M
$9.8M
Q3 24
$47.4M
$10.8M
Q2 24
$52.3M
Q1 24
$42.5M
Debt / Equity
GSIT
GSIT
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GSIT
GSIT
LSH
LSH
Operating Cash FlowLast quarter
$-7.9M
$-453.5K
Free Cash FlowOCF − Capex
$-8.2M
FCF MarginFCF / Revenue
-134.4%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GSIT
GSIT
LSH
LSH
Q4 25
$-7.9M
$-453.5K
Q3 25
$-887.0K
$-4.0M
Q2 25
$-1.7M
$-483.7K
Q1 25
$-1.7M
$-238.3K
Q4 24
$-3.6M
$-530.2K
Q3 24
$-3.5M
$-1.4M
Q2 24
$-4.3M
Q1 24
$-7.1M
Free Cash Flow
GSIT
GSIT
LSH
LSH
Q4 25
$-8.2M
Q3 25
$-906.0K
Q2 25
$-1.7M
$-497.4K
Q1 25
$-1.7M
Q4 24
$-3.6M
$-560.5K
Q3 24
$-3.5M
$-1.4M
Q2 24
$-4.3M
Q1 24
$-7.2M
FCF Margin
GSIT
GSIT
LSH
LSH
Q4 25
-134.4%
Q3 25
-14.1%
Q2 25
-27.6%
-7.9%
Q1 25
-28.3%
Q4 24
-66.1%
-15.6%
Q3 24
-76.6%
-34.5%
Q2 24
-92.0%
Q1 24
-139.0%
Capex Intensity
GSIT
GSIT
LSH
LSH
Q4 25
4.9%
Q3 25
0.3%
Q2 25
0.3%
0.2%
Q1 25
0.1%
0.0%
Q4 24
0.1%
0.8%
Q3 24
0.1%
0.1%
Q2 24
0.7%
Q1 24
0.2%
Cash Conversion
GSIT
GSIT
LSH
LSH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-3.96×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GSIT
GSIT

Distribution$5.6M92%
Other$459.0K8%

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons